THC: Tenet Health Enterprise Value to EBITDA Ratio
Streamlined equipment supply for clinics is stimulating growth, as evidenced by the shift in the EV/EBITDA multiple. The 8.01 metric indicates the status of an asset relying on strong benefit packages to retain physicians. However, intense competition for patients and pressure from insurers create profit risks, impacting the fundamental value of Tenet Healthcare (THC).
THC (tenethealth.com): analytical breakdowns and indicator data
- stock price and consensus target price:
- market capitalization information:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Capital Tenet Healthcare|THC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Tenet Healthcare Corporation|THC - Company Cumulative Indebtedness|Debt to Book Value Tenet Health|THC - Company Long-Term Loans and Borrowings|Company Short-Term Debts Tenet Healthcare|Quick Ratio tenethealth.com
- financial results and valuation multiples details:
THC - Company Net Income|Projected Future Earnings Tenet Healthcare|THC - P/E Multiple|Future Price to Earnings Tenet Healthcare|THC - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Tenet Health|THC - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Tenet Healthcare|THC - Earnings per share for the trailing year|Quarterly EPS earnings growth tenethealth.com|THC - Net earnings per share growth this year|Earnings growth forecast for next year Tenet Healthcare
General company analysis:Tenet (THC)
The operational efficiency of Tenet Healthcare (THC) clinics and their reliance on government reimbursement rates are reflected in the company's EV/EBITDA value on this chart. This metric compares the enterprise value, including debt, to operating profit before depreciation and amortization, excluding the impact of taxes. The trend of this ratio captures the actual volatility of assets and the quality of cost control. A decline in the indicator signals undervaluation, although a high debt load may offset the growth potential.
Key competitors
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio FMS (Fresenius Medical)|SOLV: Enterprise Value to EBITDA Ratio|encompasshealth.com - Enterprise Value to Operating Income Before Depreciation Ratio|UHS: EV/EBITDA Multiple|Company Value to EBITDA DaVita HealthCare Partners (DVA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RadNet Corp|Enterprise Value to Operating Income Before Depreciation OPCH (Option Care Corp)|EV/EBITDA Multiple SGRY|PINC - Company Value to EBITDA|National Vision - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PGNY (Progyny Inc)|ARDT: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation SEM (Select Medical Inc.)|ASTH: EV/EBITDA Multiple|Pediatrix Medical Group - Business Value to Operating Income Before Depreciation|USPH (US Physical Therapy) - EV/EBITDA Multiple|Company Value to EBITDA Pennant Group PNTG|EV/EBITDA Multiple ORGO|EV/EBITDA Multiple Nutex Health Hospitals (NUTX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Auna SA AUNA|sbc-holdings.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|EOLS: Enterprise Value to EBITDA Ratio|CHS - Enterprise Value to Operating Income Before Depreciation Ratio|SKIN: EV/EBITDA Multiple|MediWound - Business Value to Operating Income Before Depreciation|BTMD (biote Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio thejoint.com (JYNT)|EV/EBITDA Multiple DCGO|EV/EBITDA Multiple p3hp.org (PIII)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Gain Therapeutics, Inc. GANX|Business Value to Operating Income Before Depreciation EUDA|Basel Medical Group Limited - EV/EBITDA Multiple|Company Value to EBITDA CollPlant Biotechnologies|CUPR (Cuprina Holdings) - Enterprise Value to EBITDA Ratio|CCM: Enterprise Value to Operating Income Before Depreciation Ratio|AMS (American Shared Hospital Services, Inc.) - EV/EBITDA Multiple|MRM: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ALBT|Enterprise Value to EBITDA Ratio dih.com DHAI|Carmell Therapeutics - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NIVF (NewGenIvf Group)|ATIP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CMAX (CareMax, Inc)|KDLY: EV/EBITDA Multiple|Company Value to EBITDA modivcare.com (MODV)|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple SunLink Health Systems, Inc|Enterprise Value to EBITDA Ratio BACK (IMAC Regeneration Centers)
